Study uncovers potential therapeutic approach for advanced prostate cancer

by Melissa Rohman,Northwestern UniversityPALI1 bridges the interaction between PRC2 (SUZ12/EZH2/EED) and G9A to catalyze dual H3K9 and H3K27 methylation, which leads to strong repression of GPS

Updated on: February 01,2024

Study uncovers potential therapeutic approach for advanced prostate cancer

by Melissa Rohman,Northwestern UniversityPALI1 bridges the interaction between PRC2 (SUZ12/EZH2/EED) and G9A to catalyze dual H3K9 and H3K27 methylation, which leads to strong repression of GPS

Updated on:February 01,2024

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S

Updated on: February 18,2024

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S

Updated on:February 18,2024

Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on: June 19,2024

Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on:June 19,2024

Special RNA shown to suppress the formation of breast cancer cells

JANUARY 16, 2024by Sebastian Hollstein,Friedrich Schiller University of JenaCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2023.113644Breast cancer is the most common cancer in wom

Updated on: March 25,2024

Special RNA shown to suppress the formation of breast cancer cells

JANUARY 16, 2024by Sebastian Hollstein,Friedrich Schiller University of JenaCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2023.113644Breast cancer is the most common cancer in wom

Updated on:March 25,2024

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on: January 13,2024

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on:January 13,2024

Novel treatment effective for bladder cancer, study in mice shows

by Northwestern UniversityCredit: Unsplash/CC0 Public DomainAn epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by

Updated on: February 01,2024

Novel treatment effective for bladder cancer, study in mice shows

by Northwestern UniversityCredit: Unsplash/CC0 Public DomainAn epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by

Updated on:February 01,2024

Lactate-producing bacteria inside tumors found to promote resistance to radiation therapy

by University of Texas M. D. Anderson Cancer CenterGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.09.012Researchers at The University of Texas MD Anderson Can

Updated on: April 09,2024

Lactate-producing bacteria inside tumors found to promote resistance to radiation therapy

by University of Texas M. D. Anderson Cancer CenterGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.09.012Researchers at The University of Texas MD Anderson Can

Updated on:April 09,2024

Sex differences identified in deadly brain tumors

by Washington University School of MedicineGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0For decades, scientists have recognized that more males get cancer and die of the disease

Updated on: April 20,2024

Sex differences identified in deadly brain tumors

by Washington University School of MedicineGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0For decades, scientists have recognized that more males get cancer and die of the disease

Updated on:April 20,2024

Researchers identify a regulator of breast cancer development

by UT Southwestern Medical CenterBreast cancer stem cells (BCSCs) are responsible for breast carcinogenesis. Researchers' work reveals potential targets for killing BCSCs to prevent breast tu

Updated on: January 29,2024

Researchers identify a regulator of breast cancer development

by UT Southwestern Medical CenterBreast cancer stem cells (BCSCs) are responsible for breast carcinogenesis. Researchers' work reveals potential targets for killing BCSCs to prevent breast tu

Updated on:January 29,2024

Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease rela

Updated on: April 28,2024

Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease rela

Updated on:April 28,2024

Reprograming T cells to attack solid tumors

by Agency for Science, Technology and Research (A*STAR), SingaporeA colourful battle: Live human liver cancer cells (green) are attacked by engineered T cells (blue), resulting in a dead liver ca

Updated on: April 07,2024

Reprograming T cells to attack solid tumors

by Agency for Science, Technology and Research (A*STAR), SingaporeA colourful battle: Live human liver cancer cells (green) are attacked by engineered T cells (blue), resulting in a dead liver ca

Updated on:April 07,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on: March 05,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on:March 05,2024